91 results match your criteria: "Centre de Biologie Humaine[Affiliation]"
Microorganisms
December 2024
Agents Infectieux, Résistance et Chimiothérapie (AGIR), UR 4294, Université de Picardie Jules Verne, 1 rue des Louvels, 80037 Amiens, France.
Currently, artemisinin-based combination therapy is recommended as first-line treatment of uncomplicated malaria. Arylamino alcohols (AAAs) such as mefloquine (MQ) are the preferred partner drugs due to their longer half-life, reliable absorption and strong antimalarial activity. However, the mode of action of MQ remains poorly understood and its neurotoxicity limits its use.
View Article and Find Full Text PDFJ Clin Microbiol
December 2024
Chrono-environnement UMR6249, CNRS, University of Franche-Comté, Besançon, Bourgogne-Franche-Comté, France.
Ann Pharm Fr
December 2024
Académie nationale de pharmacie, Paris, France; Service de pharmacie, groupement hospitalier Nord, hospices civils de Lyon, Lyon, France; Malaria Research Unit, SMITh, ICBMS UMR 5246, université de Lyon, Lyon, France.
Antifungal resistance in humans is a clinical reality of increasing incidence that raises problems for patient care. In this current event, we discuss the link that can be made between the presence of antifungals in the environment and the development of resistance in humans, as well as the ecotoxicology of antifungals. The presence of antifungals in the environment has a health, but also an ecological impact.
View Article and Find Full Text PDFMed Mycol
November 2024
Laboratoire de Parasitologie et Mycologie, Centre de Biologie Humaine, CHU Amiens-Picardie, 80054 Amiens, France.
Lancet Infect Dis
October 2024
Virology Department, Hôpital Ambroise Paré, Paris, France. Electronic address:
Br J Haematol
November 2024
Service d'Hématologie Biologique, Centre de Biologie Humaine, CHU Amiens-Picardie, Amiens, France.
Anticancer Res
August 2024
UR7516, CHIMERE, Université de Picardie Jules Verne, Amiens, France;
Background/aim: How tumors regulate the genes of the coagulome is crucial for cancer-associated thrombosis and the occurrence of venous thromboembolic complications in patients with cancer. We have previously reported potent yet complex effects of glucocorticoids (GC) on the expression of three genes that play a key role in the regulation of thrombin/plasmin activation (F3, PLAU, and SERPINE1). This study aimed to extend the investigation of GC effects to the whole tumor coagulome and assess the resulting impact on the ability of cancer cells to activate thrombin and plasmin.
View Article and Find Full Text PDFHum Reprod
September 2024
Service de Médecine Interne et Inflammation-Immunopathology-Biotherapy Department (DMU I3), Hôpital Saint Antoine, Sorbonne Université AP-HP, Paris, France.
Pract Lab Med
March 2024
Clinical Affairs Department, Beckman Coulter, Immunotech, Marseille, France.
Introduction: This study evaluated the clinical and analytical performances of the Access HBsAg and the Access HBsAg Confirmatory assays on the DxI 9000 Access Immunoassay Analyzer (Beckman Coulter, Inc.).
Materials And Methods: Diagnostic specificity and sensitivity of the Access HBsAg and Access HBsAg Confirmatory assays were evaluated by comparing the Access assays to the final HBsAg sample status determined using the Architect, PRISM, or Elecsys HBsAg assays, along with Architect or PRISM HBsAg Confirmatory assays.
Cancers (Basel)
March 2024
UR7516 CHIMERE, Université de Picardie Jules Verne, 80054 Amiens, France.
Ann Clin Microbiol Antimicrob
January 2024
Laboratoire de Parasitologie et Mycologie Médicales, Centre de Biologie Humaine, CHU Amiens-Picardie, 1 rond-point du Pr Cabrol, 80054, Amiens Cedex 1, France.
Background: Pneumocystis jirovecii (P. jirovecii) is an opportunistic fungus responsible for Pneumocystis pneumonia (PCP) in deeply immunocompromised patients and for pulmonary colonization in individuals with mild immunosuppression or impaired respiratory function. PCP and Cytomegalovirus (CMV) co-infections have been widely described whereas those involving other Herpesviruses (HVs) such as Epstein-Barr virus (EBV), Herpes simplex virus type 1 and type 2 (HSV-1 and -2), and Varicella zoster virus (VZV) remain scarce.
View Article and Find Full Text PDFAnn Vasc Surg
November 2023
EA Chimere, 7516, Université Picardie Jules Vernes, Amiens, France; Department of Vascular Medicine, Amiens, France. Electronic address:
Background: For complex extensive TASC-II D lesions, the standard of care remains conventional surgery. Nevertheless, guidelines tend to broaden endovascular surgery indications in expert centers for patients at high surgical risk with TASC-II D lesions. Due to the increasing use of endovascular surgery in this setting, we planned to evaluate the patency rate of this approach.
View Article and Find Full Text PDFCurr Opin Otolaryngol Head Neck Surg
April 2023
UR7516, CHIMERE, Université de Picardie Jules Verne.
Purpose Of Review: Solid tumors often establish a locally hypercoagulant state that promotes vascular complications, such as venous thromboembolism (VTE). Oral squamous cell carcinoma (OSCC) is associated with a broad range of hemostatic complications. Although VTE rarely occurs in ambulatory patients with OSCC, the coagulation cascade is typically activated by surgical resection and local hemorrhage.
View Article and Find Full Text PDFCancers (Basel)
February 2023
UR7516, CHIMERE, Université de Picardie Jules Verne, 80054 Amiens, France.
Background: The coagulome, defined as the repertoire of genes that locally regulate coagulation and fibrinolysis, is a key determinant of vascular thromboembolic complications of cancer. In addition to vascular complications, the coagulome may also regulate the tumor microenvironment (TME). Glucocorticoids are key hormones that mediate cellular responses to various stresses and exert anti-inflammatory effects.
View Article and Find Full Text PDFJ Nephrol
May 2023
Department of Virology, Amiens University Hospital, Amiens, France.
J Stomatol Oral Maxillofac Surg
February 2023
Sorbonne Université, Paris, France ; Department of Maxillo-Facial Surgery, Hôpital Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris, 47-83 boulevard de l'Hôpital, Paris 75013, France ; Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon 69008, France.
Blood Adv
September 2023
Service d'Hématologie Biologique, Centre de Biologie Humaine, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France.
Med Sci (Paris)
July 2022
UR7516 CHIMERE (Chirurgie, imagerie et régénération tissulaire de l'extrémité céphalique), université de Picardie Jules Verne, Amiens, France - Institut Faire Face, CHU Amiens, 80054 Amiens, France - Service de chirurgie maxillo-faciale, CHU Amiens, 80054 Amiens, France.
Surgical resection is the most frequent curative treatment proposed to patients with head and neck cancers. It is currently integrated into specific therapeutic schemes and therapeutic stratification, but the surgical procedure itself as well as its evaluation do not rely on tumor biology. Here, we present a number of recent studies, mostly based on system analyses and genomics, that show how tumor analyses could help to: i) define the indications and the extent of surgical resections; ii) personalize the perioperative management; iii) facilitate the detection of post-surgical tumor recurrence.
View Article and Find Full Text PDFJ Infect
July 2022
Centre d'Immunologie et des Maladies Infectieuses, Sorbonne-Université, INSERM, (U1135 - E2), 4 rue de la Chine, Paris 75020, France; Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Bactériologie-Hygiène, AP-HP. Sorbonne Université, Site Pitié Salpêtrière, Paris, France.
Objectives: Isoniazid-monoresistant tuberculosis (HR-TB) requires early diagnosis and adapted treatment to achieve optimal outcomes. The primary aim of the study was to assess the impact of the implementation of rapid diagnostic tests on HR-TB treatment in France.
Methods: We designed a retrospective multicentre study including consecutive HR-TB patients diagnosed in 2016 and 2017.
Front Oral Health
April 2022
Department of Otorhinolaryngology, Head and Neck Surgery, University of Brescia, Brescia, Italy.
Front Oral Health
January 2022
EA7516 CHIMERE, Université de Picardie Jules Verne, Amiens, France.
The perioperative period is the relatively short window of time, usually measured in days or weeks, around the surgical procedure. Despite its short duration, this time period is of great importance for cancer patients. From a biological point of view, the perioperative period is complex.
View Article and Find Full Text PDFTrends Cancer
May 2022
Laboratoire de Biochimie, Centre de Biologie Humaine, CHU Sud, Amiens, France; UR7516 'CHIMERE', Université de Picardie Jules Verne, Amiens, France.
Human tumors often trigger a hypercoagulable state that promotes hemostatic complications, including venous thromboembolism. The recent application of systems biology to the study of the coagulome highlighted its link to shaping the tumor microenvironment (TME), both within and outside of the vascular space. Addressing this link provides the opportunity to revisit the significance of biomarkers of hemostasis and assess the communication between vasculature and tumor parenchyma, an important topic considering the advent of immune checkpoint inhibitors and vascular normalization strategies.
View Article and Find Full Text PDFClin Infect Dis
September 2022
Université de Strasbourg, INSERM, IRFAC UMR-S1113, Strasbourg, Franceand.
Front Microbiol
August 2021
Laboratoire de Parasitologie-Mycologie, Centre de Biologie Humaine, CHU Amiens-Picardie, Amiens, France.
Transl Oncol
August 2021
Laboratoire de Biochimie, Centre de Biologie Humaine (CBH), CHU Sud, Amiens, France; UR7516 "CHIMERE", Université de Picardie Jules Verne, Amiens, France. Electronic address:
Objectives: The immune checkpoint molecule PD-L1 (CD274) is a crucial regulator of the tumor immune response. Its expression has been reported in the therapeutic context in Head and Neck Squamous Cell Carcinoma (HNSCC), but it remains unclear how therapeutically approved molecules regulate PD-L1 expression in HNSCC cells.
Materials And Methods: Three HNSCC cell lines (BICR6, PE/CA-PJ34 and PE/CA-PJ41) were used to analyze PD-L1 expression by immunoblotting, immunofluorescence and QPCR.